Related Experiment Video

Updated: Jun 3, 2026

Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates
11:32

Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates

Published on: August 6, 2021

Mitochondria determine the efficacy of anticancer agents that interact with DNA but not the cytoskeleton

Kenjirou Hara1, Emiko Kasahara, Nozomi Takahashi

  • 1Department of Biochemistry and Molecular Pathology, Osaka City University Medical School, Asahimachi 1-4-3, Abeno, Osaka, Japan.

The Journal of Pharmacology and Experimental Therapeutics
|March 23, 2011
PubMed

Insights

Mitochondria are crucial for chemotherapy efficacy. DNA-targeting drugs induce cancer cell death via mitochondrial reactive oxygen species (ROS), while cytoskeleton-targeting drugs bypass mitochondria.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Chemotherapy's effectiveness is limited by variable cancer cell sensitivity and normal tissue side effects.
  • Mitochondria's role in cancer cell apoptosis induced by chemotherapy agents is not fully understood.

Purpose of the Study:

  • To investigate the role of mitochondria in cancer cell apoptosis induced by DNA-interacting versus cytoskeleton-interacting anticancer agents.
  • To determine if mitochondrial DNA (mtDNA) is a target for DNA-interacting chemotherapy agents.

Main Methods:

  • Comparing apoptosis induction in mesothelioma H2052 cells and their mtDNA-deficient ρ(0) counterparts.
  • Measuring reactive oxygen species (ROS) generation in mitochondria.
  • Assessing the activation of caspase-9, caspase-8, and caspase-3.

Main Results:

  • DNA-interacting agents induced apoptosis via mitochondrial ROS, cytochrome c release, and caspase activation, dependent on mtDNA.
  • Cytoskeleton-interacting agents induced apoptosis independently of mitochondria and ROS, activating caspase-8 and caspase-3.
  • Cancer cell sensitivity to DNA-interacting agents correlated positively with mitochondrial content.

Conclusions:

  • Mitochondrial DNA is a potential target for DNA-interacting anticancer agents, inducing ROS-dependent apoptosis.
  • Cytoskeleton-targeting agents induce apoptosis through a mitochondria- and ROS-independent pathway.
  • Understanding these distinct mechanisms can guide chemotherapy selection for cancer patients.

More Related Videos

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity07:58

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

Transmitochondrial Cybrid Generation Using Cancer Cell Lines07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...